Life sciences briefing: Monday, Feb. 11, 2008
TODAY’S HEADLINES:
PolyRemedy, developer of robotic wound care, takes in $25M (release)
Bacchus Vascular gets $15M for clot-busting device (VentureWire)
Protein-evolution company Modular Genetics gets $1.2M (VentureWire)
PharmatrophiX gets $300K for Alzheimer’s disease prevention drugs (release)
Light Sciences Oncology withdraws IPO (Edgar)
Arizona’s Translational Accelerator launches $20M life-sciences fund (bizjournals.com)
Cornea-reshaper Avedro… Continue Reading
Life sciences briefing: Thursday, Jan. 31, 2007
TODAY’S HEADLINES:
5AM Ventures puts $3.3M into stealthy ImmunoNewco (VBLS exclusive)
NewLink Genetics raises $17M for cancer vaccine, immune drugs (VBLS exclusive)
Biochip, stem-cell biotech Minerva Bio ousts CEO Jim Czirr and sues (release)
Sonexa Therapeutics takes $30M for Alzheimer’s treatment (release)
Tissue regenerator Healionics pulls in $1.7M (release)
EGeen, clinical… Continue Reading
Satoris raises $5M, preps Alzheimer’s test for research use
Redwood City, Calif.-based Satoris, a biotech developing a blood test for Alzheimer’s disease, raised $5 million in a second funding round, VentureWire reports. The deal values Satoris at $13.8 million after the financings. The company had previously raised $1 million from individuals, and said it… Continue Reading
Life sciences briefing: Friday, Jan. 18, 2007
TODAY’S HEADLINES:
Ulthera receives $23M for cosmetic ultrasound devices (release)
Senexis raises £2.9M for Alzheimer’s drugs (PDF release)
Elixir Pharma postpones IPO (IPO Home)
Cancer Therapeutics names Randall Riggs as CEO (release)
Ulthera receives $23M for cosmetic ultrasound devices — Ulthera, a Mesa, Ariz., startup developing ultrasound systems for cosmetic… Continue Reading
Life sciences briefing: Wednesday, Dec. 5, 2007
Featured companies: AxoGen, Cognition Therapeutics, Ester Neurosciences, Gene Security Network, HealthTalk, MPM Capital, Revolution Health, SparkPeople
UPDATING: Expanded items on AxoGen, Ester and Cognition. Posted full items on MPM (link) and Gene Security Network (link).
AxoGen raises $12M for nerve regeneration — AxoGen, an Alachua, Fla., biotech focused on… Continue Reading
Life sciences briefing: Monday, Dec. 3, 2007
Featured companies: CoMentis, ForHealth Technologies, Merrimack Pharmaceuticals, QuantomiX, Progenitor Cell Therapy, River Diagnostics, Topaz Pharmaceuticals
UPDATED: Expanded items on CoMentis, Topaz and ForHealth.
CoMentis gets $12M for eye, Alzheimer’s treatments — South San Francisco’s CoMentis, a biotech pursuing treatments for Alzheimer’s disease and macular degeneration, raised $12 million in… Continue Reading
Satoris seeks $5M for Alzheimer’s test — with high errors
Satoris, a Redwood City, Calif., biotech developing a diagnostic test for Alzheimer’s disease, is close to raising $5 million in a second funding round, VentureWire reports (subscription required). The funds will allow the company to make its test available to outside researchers.
Satoris made a big… Continue Reading
Life sciences briefing: Friday, Oct. 12, 2007
Featured companies: CeraPedics, Lab21, Incisive Surgical, Orasi Medical, Transoma Medcal, ZyGem
(UPDATED: Expanded items on Transoma, Lab21 and Orasi.)
Medical-device maker Transoma files for $75M IPO — St. Paul, Minn.-based Transoma Medical, a developer of implantable wireless diagnostic sensors, filed to raise $75 million in an initial offering. The… Continue Reading
Best of the blogosphere on disease genetics
The thirteenth edition of Gene Genie, a biweekly collection of the blogosphere’s best posts on disease genetics, is up at the Genetic Geneologist, courtesy of proprietor Blaine Bettinger.
The roundup includes posts on:
the Personal Genome Project, George Church’s effort to sequence the genomes of ten volunteers;… Continue Reading
Life sciences briefing: Friday, Aug. 10, 2007
(CORRECTED: See below.)
Featured companies: VistaGen Therapeutics, MindWeavers, Cutanea Life Sciences, Heptares Therapeutics
VistaGen raises $3.75M for stem-cell based drug discovery — South San Francisco, Calif.-based VistaGen Therapeutics, a biotech that uses human embryonic stem cells to discover new drugs, raised $3.75 million in a bridge financing as it… Continue Reading
Roundup: Anemia drugs under assault, stem-cell trial moves forward, medical interventions and poor “quality of death,” and more
Is the bell tolling for EPO? – The news keeps going from bad to worse for the wonder drugs of biotech — the anemia treatments known as ESAs or EPO, shorthand for “erythropoiesis stimulating agents” and “erythropoietin,” respectively. Earlier today, an FDA advisory panel recommended new… Continue Reading
Avid Radiopharmaceuticals, maker of imaging reagents, raises $26M for clinical trials
Avid Radiopharmaceuticals, a Philadelphia-based maker of “molecular imaging agents” that help highlight diseased tissue in various medical scans, raised $26 million in a third round to develop early-detection products for Alzheimer’s and Parkinson’s disease.
AllianceBernstein and Safeguard Scientifics led the round. Previous investors including Pfizer Strategic… Continue Reading